What Is Premenstrual Dysphoric Disorder (PMDD)? A Complete Guide to Symptoms, Diagnosis, and the ADHD Link

Premenstrual dysphoric disorder (PMDD) is a severe, debilitating form of premenstrual distress that affects 3–8% of women of reproductive age, according to the Norwegian public health authority Helse Norge. Unlike typical PMS, PMDD symptoms emerge in the luteal phase—the week before menstruation—and can significantly impair daily functioning. This guide covers what PMDD is, how it differs from PMS, how it is diagnosed, and what recent research reveals about its relationship with ADHD.

Sist kontrollert: 2026-10-03

Hva er PMDD?: Premenstruell dysforisk forstyrrelse, en alvorlig form for PMS · Prevalens: Ca. 3–8 % av kvinner · Symptomer: Nedstemthet, angst, uro, depressive følelser i 1–2 uker før menstruasjon · Forskjell fra PMS: Mer alvorlig og påvirker hverdagen betydelig

Key Facts About PMDD

What Is PMDD?

Premenstrual dysphoric disorder (PMDD) is a severe, clinically significant form of premenstrual syndrome, according to Helse Norge. The condition is characterized by marked psychological and physical symptoms that emerge during the luteal phase—the interval between ovulation and the onset of menstruation—and that substantially interfere with a woman’s ability to function in work, school, or social settings.

Symptoms commonly include depressed mood, irritability, anxiety, mood swings, difficulty concentrating, sleep disturbances, and physical complaints such as breast tenderness, bloating, and joint pain. To meet the diagnostic threshold, at least five of eleven recognized symptoms must be present, with at least one being a core mood symptom like irritability, dysphoria, or anxiety, as detailed in StatPearls.

PMDD affects an estimated 3–8% of women of reproductive age (Helse Norge). Although the exact cause remains under investigation, current research points to an abnormal sensitivity to normal fluctuations in ovarian hormones—specifically estrogen and progesterone—rather than to abnormal hormone levels themselves.

How Does PMDD Differ From PMS?

The distinction between PMDD and premenstrual syndrome (PMS) lies primarily in the severity and the degree of functional impairment, not in the timing of symptoms. Both conditions occur during the luteal phase and improve within days after menstruation begins, according to ACOG.

While PMS is common—affecting up to 75% of women at some point—and produces mild to moderate discomfort, PMDD is less common and far more disabling. The ACOG emphasizes that PMDD symptoms must significantly impair functioning in at least one domain of life, such as work performance, academic achievement, or interpersonal relationships, to warrant a diagnosis.

The table below summarizes the key clinical differences:

Note that the diagnosis of PMDD should not be made based on a single cycle. Helse Norge recommends that women who suspect PMDD track their symptoms daily for at least two menstrual cycles to confirm the cyclical pattern.

How Is PMDD Diagnosed?

The diagnostic process for PMDD is deliberate and relies on prospective symptom documentation. According to Helse Norge, the diagnosis is confirmed only after daily symptom tracking over a minimum of two consecutive menstrual cycles.

DSM-5 Diagnostic Criteria

As outlined in StatPearls, the DSM-5 criteria for PMDD include:

1. Five or more symptoms from a list of eleven, present in the week before menses.
2. At least one core mood symptom: depressed mood, anxiety, marked irritability, or mood swings.
3. Symptoms improve within a few days after the onset of menses and are absent in the week after menses.
4. Significant functional impairment in work, school, social, or interpersonal functioning.
5. Exclusion of other disorders such as major depression, panic disorder, or bipolar disorder.

The Diagnostic Timeline

Prospective daily tracking is the cornerstone of PMDD diagnosis. The process typically unfolds as follows:

A key challenge for clinicians is distinguishing PMDD from premenstrual exacerbation of an underlying mood disorder (such as depression or anxiety). In such cases, the underlying condition persists throughout the cycle, whereas PMDD symptoms resolve completely during the follicular phase.

What Is the Connection Between PMDD and ADHD?

Recent research has revealed a notable overlap between PMDD and attention deficit hyperactivity disorder (ADHD). A review in PubMed Central found that symptoms such as difficulty concentrating, irritability, and emotional dysregulation can occur in both conditions, potentially leading to diagnostic confusion.

Shared Symptoms and Their Implications

The Estrogen-ADHD Connection

Research published in another PubMed Central article suggests that lower estrogen levels during the luteal phase may exacerbate ADHD symptoms, particularly inattention, in women with both conditions. A Norwegian clinical guideline in Metodebok further notes that ADHD symptoms and the effectiveness of ADHD medication can worsen during this phase.

How to Distinguish PMDD From ADHD

According to StatPearls, the most reliable differentiator is timing. A clear cyclical pattern—where symptoms appear exclusively in the luteal phase and resolve fully with menstruation—strongly suggests PMDD or premenstrual exacerbation of ADHD. In contrast, ADHD symptoms typically persist throughout the entire cycle, even if they intensify in the premenstrual period.

For women with both conditions, the interaction can be bidirectional. The mood symptoms of PMDD can amplify the inattention and impulsivity of ADHD, while the chronic demands of managing ADHD may lower tolerance for premenstrual mood changes. Helse Norge recommends that women with suspected PMDD and comorbid ADHD receive a multidisciplinary assessment to ensure accurate diagnosis and appropriate treatment.

Treatment Overview for PMDD

While a comprehensive treatment guide is beyond the scope of this article, Helse Norge and ACOG outline several evidence-based approaches:

• Lifestyle modifications: Regular aerobic exercise, adequate sleep, stress reduction, and a diet rich in complex carbohydrates.
• Nutritional supplementation: Calcium (600 mg twice daily), vitamin B6 (50–100 mg daily), and magnesium may reduce symptom severity.
• Cognitive behavioral therapy (CBT): Helps manage mood symptoms and improve coping strategies.
• SSRI medication: Selective serotonin reuptake inhibitors (e.g., fluoxetine or sertraline) are effective for mood symptoms, often taken only during the luteal phase.
• Hormonal contraceptives: Combined oral contraceptives containing drospirenone and ethinyl estradiol have been shown to reduce PMDD symptoms.
• GnRH agonists: Reserved for severe cases under specialist supervision, these drugs suppress ovulation and may be used with add-back hormone therapy.

Relatert lesning: ?

Frequently Asked Questions About PMDD

Sources

1. Helse Norge – PMDD (Premenstrual Dysphoric Disorder). helsenorge.no/sykdom/underliv/pmdd
2. StatPearls – Premenstrual Dysphoric Disorder. ncbi.nlm.nih.gov/books/NBK532307
3. ACOG – Premenstrual Syndrome (PMS). acog.org/womens-health/faqs/premenstrual-syndrome
4. PubMed Central – Symptom overlap between PMDD and ADHD. pmc.ncbi.nlm.nih.gov/articles/PMC10711063
5. Metodebok – Premenstrual exacerbation and ADHD. metodebok.no
6. PubMed Central – Estrogen and ADHD symptom severity. pmc.ncbi.nlm.nih.gov/articles/PMC12786913